New trial opening for Relapsing Osteosarcoma patients

Little has changed in our medical treatment for the most common Bone Sarcoma in children, Osteosarcoma, over the past 30+ years.  Several phase I trials and translational studies show promise for those patients battling relapsed or progressive disease.  A phase II COG trial is about to open for relapsing patients using Denosumab in combination with other agents.  Details of the study can

https://clinicaltrials.gov/ct2/show/NCT02470091

Subscribe To Our Newsletter

Enter your email below to join our mailing list.